Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.026 | 0.6 |
mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.014 | 0.6 |